The Uromigos
Un pódcast de The Uromigos
401 Episodo
-
Episode 264: Prostatectomy vs RT vs surveillance- the PROTECT trial
Publicado: 27/9/2023 -
Episode 263: Toni Choueiri and papillary renal cancer
Publicado: 20/9/2023 -
Episode 262: Paper of the month abiraterone +/- cabazitaxel in CRPC.
Publicado: 12/9/2023 -
Episode 261: part 2 ctDNA in bladder cancer
Publicado: 4/9/2023 -
Episode 260: Celeste Simon: how to make a career in translation science work.
Publicado: 30/8/2023 -
Episode 259: Cystectomy for bladder cancer
Publicado: 24/8/2023 -
Episode 258: Curative radiotherapy for bladder cancer: Golden Ticket Winner #1
Publicado: 15/8/2023 -
Episode 257: Chana Weinstock from the FDA
Publicado: 7/8/2023 -
Episode 256: ctDNA in urothelial studies.
Publicado: 27/7/2023 -
Episode 255: How to get an academic paper accepted
Publicado: 26/7/2023 -
Episode 254: New RCC studies at KCRS 2023 with Laurence Albiges
Publicado: 17/7/2023 -
Episode 253: Patients' perspectives on adjuvant and 1st line RCC
Publicado: 13/7/2023 -
Episode 252: Talazoparib and its FDA approval in CRPC
Publicado: 4/7/2023 -
Episode 251: Final part of VEGF/TKI vs IPI/NIVO discussion
Publicado: 26/6/2023 -
Episode 250: Bob Motzer discusses IPI/Nivo vs VEGF/PD1
Publicado: 18/6/2023 -
Episode 249: ASCO 2023 emergency podcast IPI/NIVO vs VEGF/PD1 in kidney cancer
Publicado: 18/6/2023 -
Episode 248: ASCO23 GU highlights
Publicado: 14/6/2023 -
Episode 246: ASCO 2023: EV pembro and erdafitinib +/- cetrelimab in 1st line UC
Publicado: 5/6/2023 -
Episode 245: ASCO 2023 - CONTACT-03 cabozantinib +/- atezolizumab in renal cancer
Publicado: 5/6/2023 -
Episode 244: ASCO 2023 PEACE-1 in CRPC
Publicado: 5/6/2023
Broadcasting the latest developments in GU cancer Hosted by Brian Rini and Tom Powles Brian Rini MD is a Professor of Cancer Research and Professor of Medicine (Hematology/Oncology), Vanderbilt-Ingram Cancer Center Tom Powles is the Director of Barts Cancer Centre, St Bartholomew's Hospital and Professor of Genitourinary Oncology, Queen Mary University of London
